Search Results

Displaying Results 1-1 of 1 "'IPAX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
TLX101-Px (Pixlumi®) MAA Accepted in Europe

Apr 30, 2026, 21:07 ET TLX101-Px (Pixlumi®) MAA Accepted in Europe

TLX101-Tx (iodofalan 131I), Telix's LAT1-targeting glioblastoma (GBM) therapy candidate, currently under investigation in Telix's IPAX-2[13] and IPAX-BrIGHT studies. TLX101-Px and TLX101-Tx have not received marketing authorizations in any jurisdiction. In relevant European markets, the

More news about: Telix Pharmaceuticals Limited

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.